X
Get new exclusive access to healthcare business reports & breaking news
Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.
The U.S. Food and Drug Administration (FDA) approved Esperion’s NEXLETOL™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-Cholesterol ...
Roche was supposed to receive the FDA decision regarding the subcutaneous version of its cancer immunotherapy Tecentriq last ...
Moderna, Inc. announced September 6th that clinical trial data from its research assay confirm its updated COVID-19 vaccine, ...
GE HealthCare announced August 14th it has received 510(k) clearance from the United States Food and Drug Administration ...
Genesis Therapeutics, a company which uses artificial intelligence (AI) technologies to develop breakthrough medicines for patients with severe ...
Moderna, Inc. announced August 17th that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall ...
Pfizer Inc. announced August 21st that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial ...
Moderna Inc, a biotechnology company pioneering messenger RNA therapeutics and vaccines, on August 3rd forecast $6-8 billion in ...
Drugmaker Eli Lilly’s shares soared 17% to an all-time-high August 8th, making it the most valuable healthcare company ...
